Status:
UNKNOWN
Using Biovitals® Sentinel to Monitor Disease Progression in Subjects Quarantined for Suspected COVID-19
Lead Sponsor:
The University of Hong Kong
Conditions:
COVID19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The novel coronavirus (COVID-19) emerged in December 2019, and in mere months has spread to more than 104 countries, resulting in an outbreak of viral pneumonia worldwide. Current local quarantine po...
Detailed Description
Owing to the massive outbreak of COVID-19, as of March 9, 2020, the virus has reportedly caused 108,618 infections and 3,800 deaths globally. The World Health Organization (WHO) has declared COVID-19 ...
Eligibility Criteria
Inclusion
- Adult subjects ≥18 years of age
- Quarantined as suspected COVID-19
- Asymptomatic upon enrolment
- All subjects give written informed consent
Exclusion
- \- Failure to provide written informed consent
Key Trial Info
Start Date :
April 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 31 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04343794
Start Date
April 1 2020
End Date
January 31 2022
Last Update
April 15 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Hong Kong, Queen Mary Hospital
Hong Kong, Hong Kong